Clinical Edge Journal Scan

Dietary Phytochemical Index and Migraine Headache: Is There a Link?


 

Key clinical point: A higher dietary phytochemical index (DPI) score is associated with lower migraine frequency and improved migraine-related disability in patients with migraine.

Major finding: Patients with migraine in the third vs first tertile of the DPI showed a significant reduction in migraine frequency (incidence rate ratio 0.84; Ptrend = .009) and an improvement in migraine-related disability (β −2.48; Ptrend = .046). However, no significant association was seen between DPI and headache duration (Ptrend = .439), headache severity (Ptrend = .239), depression (Ptrend = .480), anxiety (Ptrend = .655), and stress (Ptrend = .876).

Study details: This cross-sectional study evaluated the association between DPI and the clinical and psychological characteristics of migraine headaches in 262 patients with migraine (age 20-50 years).

Disclosures: This study was supported by the Isfahan University of Medical Sciences, Isfahan, Iran. The authors declared no conflicts of interest.

Source: Amani Tirani S, Balali A, Kazemi M, et al. The predictive role of the dietary phytochemical index in relation to the clinical and psychological traits of migraine headaches. Sci Rep. 2024;14:6886 (Mar 22). doi: 10.1038/s41598-024-57536-7 Source

Recommended Reading

Tension, Other Headache Types Robustly Linked to Attempted, Completed Suicide
Migraine ICYMI
First Long-Term Data on Atogepant for Migraine Prevention
Migraine ICYMI
IV Ketamine Promising for Severe Refractory Headache in Children
Migraine ICYMI
Vaporized Cannabis for Acute Migraine Yields Rapid, Sustained Relief
Migraine ICYMI
Lidocaine Nerve Block Effective for Severe, Refractory Migraine in Children
Migraine ICYMI
High-Dose Eicosapentaenoic Acid as a Promising Prophylactic Treatment for Episodic Migraine
Migraine ICYMI
Early Erenumab Outperforms Non-specific Oral Treatments in Migraine Patients With Prior Treatment Failures
Migraine ICYMI
Positive Impact of Anti-CGRP Monoclonal Antibodies on Sleep Quality in Migraine
Migraine ICYMI
Patients With Chronic Kidney Disease Experiences Modestly Lower Risk for Migraine
Migraine ICYMI
Meta-analysis Identifies Atopic Dermatitis as Potential Risk Factor for Headache Disorder or Migraine
Migraine ICYMI